Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study. (Q33888604)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10656425%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10656425%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

main subject

angiogenesis inhibitor

1 reference

Brewer GJ

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10656425%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Dick RD

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10656425%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Grover DK

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10656425%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

LeClaire V

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10656425%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Tseng M

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10656425%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Wicha M

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10656425%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Pienta K

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10656425%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Redman BG

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10656425%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Jahan T

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10656425%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sondak VK

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10656425%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Strawderman M

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10656425%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

LeCarpentier G

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10656425%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Merajver SD

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10656425%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10656425%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

published in

Clinical Cancer Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10656425%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10656425%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10656425%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

1-10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10656425%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Identifiers

1 reference